Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
04/2014
04/03/2014WO2013192576A3 Oligonucleotide-based inhibitors comprising locked nucleic acid motif
04/03/2014WO2012047525A3 Folate conjugates for treating inflammation of the eye
04/03/2014WO2012031046A3 Lipids suitable for liposomal delivery of protein-coding rna
04/03/2014US20140094399 Biodegradable poly(beta-amino esters) and uses thereof
04/03/2014US20140093485 Thymidylate kinase fusions and uses thereof
04/03/2014US20140093476 Methods for treating pain
04/02/2014EP2712630A1 Mitochondrial expression vector and process for the transformation of mitochondria
04/02/2014EP2712321A2 Ureaplasma vaccine and antibody for prevention and treatment of human, animal and cell culture infection
04/02/2014CN103695556A Kit applied in oral cancer diagnosis, prevention or treatment, and drug
04/02/2014CN103695470A Lentivirus recombinant expression vector/recombinant lentivirus, as well as application, host cell and preparing method thereof
04/02/2014CN103695464A Micro RNA expression vector and application
04/02/2014CN103695429A Small interfering RNA (Ribonucleic Acid) and recombinant vector for knocking down Syntaxin6 and application of small interfering RNA and recombinant vector
04/02/2014CN103695428A Small interfering RNA (Ribonucleic Acid) and recombinant vector for knocking down Syntaxin8 and application of small interfering RNA and recombinant vector
04/02/2014CN103695427A Small interfering RNA (Ribonucleic Acid) and recombinant vector for knocking down VPS11 (Vacuolar Protein Sorting-Associated Protein 11), and application of small interfering RNA and recombinant vector
04/02/2014CN103695426A Small interfering RNA (Ribonucleic Acid) and recombinant vector for knocking down Syntaxin7 and application of small interfering RNA and recombinant vector
04/02/2014CN103695425A Small interfering RNA (Ribonucleic Acid) and recombinant vector for knocking down Syntaxin16 and application of small interfering RNA and recombinant vector
04/02/2014CN103695424A Small interfering RNA (Ribonucleic Acid) and recombinant vector for knocking down DLL4 (Delta-like Ligand 4) and application of small interfering RNA and recombinant vector
04/02/2014CN103695421A SiRNA (Ribonucleic Acid) for specifically inhibiting p21 gene expression and application thereof
04/02/2014CN103695420A Double-chain siRNA molecule and application thereof
04/02/2014CN103695372A Mesenchymal stem cell (MSC) line for stably expressing siRNA
04/02/2014CN103695327A Oral recombinant yeast and application of target enteric canal DC (dentritic cell) presenting shRNA (short hairpin ribonucleic acid) mediated thereby
04/02/2014CN103694315A Cdc45l peptides and vaccines including the same
04/02/2014CN103690928A Novel cancer antigen eef2
04/02/2014CN103007293B Targeting polypeptide-gene composite as well as preparation method and application of composite
04/02/2014CN102940890B Gene application in inhibition and apoptosis of glioma cell
04/02/2014CN102911267B TB/HIV (tuberculosis/human immunodeficiency virus) antigen peptide bispecific TCR (T cell receptor) as well recombinant retroviral vector and application thereof
04/02/2014CN102886050B Application of miRNA-489 and medicinal composition
04/02/2014CN102851292B siRNA sequences specifically silencing gI and gE gene of Marek's disease virus, and vector and preparation thereof
04/02/2014CN102747083B Application of splicing factor oncoprotein SF2/ASF in preparation of medicines used for treating leukemia
04/02/2014CN102703456B Action target site of death-associated protein kinase (DAPK3) gene hsa-miR-20a
04/02/2014CN102643858B Efficiently-replicated human hepatitis B virus recombinant vector and application thereof
04/02/2014CN102505022B RNA interference vector capable of simultaneously silencing multiple ligands of NKG2D, and construction method and application thereof
04/02/2014CN102387784B Lyophilized recombinant vwf formulations
04/02/2014CN102369282B Nucleic acid complex and nucleic acid-delivering composition
04/02/2014CN102205132B Preparation formula of gene therapy medicament taking recombinant adeno-associated virus (rAAV) as vector
04/02/2014CN102038936B Application of SIRT1 (silent mating type information regulation-1) in preparing upregulation globin gene expression and preparing medicine for curing anemia
04/02/2014CN102031254B Human miR-150 antisense nucleic acid and application thereof
04/01/2014US8686128 Agent for targeting c-Jun mRNA
04/01/2014US8686052 Targeting agent for cancer cell or cancer-associated fibroblast
04/01/2014US8685938 Methods to enhance T-cell mediated immune response
04/01/2014US8685929 Detecting CYP24 expression level as a marker for predisposition to cancer
04/01/2014US8685694 Methods and compositions comprising bacteriophage nanoparticles
04/01/2014US8685635 Dermal micro-organs, methods and apparatuses for producing and using the same
04/01/2014US8685416 Compositions and methods for the treatment of cancer
04/01/2014US8685415 Mycobacterium mutants for vaccines with improved protective efficacy
04/01/2014US8685387 Simian E adenoviruses SAdV-39, -25.2, -26, -30, -37, and -38
04/01/2014US8685384 Recombinant cancer cell secreting modified heat shock protein-antigenic peptide complex
04/01/2014CA2498523C Human cd3-specific antibody with immunosuppressive properties
04/01/2014CA2493928C Nucleic acids and corresponding proteins entitled 273p4b7 useful in treatment and detection of cancer
04/01/2014CA2423122C Closure of bacterial ghosts
04/01/2014CA2420062C Erbb4 antagonists
03/2014
03/27/2014WO2014047649A1 Methods for arranging and packing nucleic acids for unusual resistance to nucleases and targeted delivery for gene therapy
03/27/2014WO2014047546A2 Use of mir-494 to modulate trail-induced apoptosis through bim down-regulation
03/27/2014WO2014044690A1 Improved vaccines
03/27/2014WO2011160126A3 S-adenosyl-(l)-homocysteine (sah) riboswitches and compositions and uses thereof
03/27/2014US20140088179 Methods and compositions for treating brain diseases
03/27/2014US20140088176 Gene transfer for regulating smooth muscle tone
03/27/2014US20140087384 Distinguishing pca3 messenger rna species in benign and malignant prostate tissues
03/27/2014US20140087002 Autologous Lymph Node Transfer In Combination With VEGF-C Or VEGF-D Growth Factor Therapy to Treat Lymphedema And To Improve Reconstructive Surgery
03/27/2014US20140086886 Stem Cell, Precursor Cell, or Target Cell-Based Treatment of Multi-Organ Failure and Renal Dysfunction
03/26/2014EP2711420A1 Method of selectively driving gene expression in anaerobic tissue by alcohol dehydrogenase promoter and uses thereof
03/26/2014EP2711376A1 Fgfr-fc fusion protein and use thereof
03/26/2014EP2711017A1 Immunity inducing agent
03/26/2014EP2710124A1 Neuronal progenitor cells and uses
03/26/2014EP2709673A2 Method for treating non-small cell lung cancer
03/26/2014EP2709672A2 Compositions and methods for treating retinal diseases
03/26/2014EP2709671A1 Method
03/26/2014EP2709670A2 Targeted delivery of proteins across the blood brain barrier
03/26/2014EP2709662A1 Use of anti-cgrp or anti-cgrp-r antibodies or antibody fragments to treat or prevent chronic and acute forms of diarrhea
03/26/2014CN103687946A Peptide for inducing regeneration of tissue and use thereof
03/26/2014CN103687626A Compositions and methods for treating retinal diseases
03/26/2014CN103687625A Cross-protective arenavirus vaccines and their method of use
03/26/2014CN103687590A Porous nanoparticle-supported lipid bilayers (protocells) for targeted delivery and methods of using same
03/26/2014CN103667431A Applications and human related drugs of CCCH-type zinc finger protein expression gene
03/26/2014CN103667430A Application and relevant medicament of nucleotide octamer binding protein expression gene
03/26/2014CN103667424A Usage of human EIF3H gene and related medicaments
03/26/2014CN103667423A Use and related medicine of human IFITM3 gene
03/26/2014CN103667422A Use and related medicament of human CUL4B gene
03/26/2014CN103667351A Application of recombinant virus vaccine in galliformes poultry by adopting duck virus enteritis virus vaccine strain as vector
03/26/2014CN103667347A Adenovirus capable of expressing anti-cancer gene efficiently, regulated by miRNA and capable of specifically proliferating in glioma cells and application thereof
03/26/2014CN103667345A Anti-oncogene magnetic composite nanoparticle and preparation method thereof
03/26/2014CN103667344A Method for activating expression of erythrogenin genes
03/26/2014CN103667304A Nucleic acids
03/26/2014CN103667300A Pichia pastoris-optimized oncorhynchus mykiss hepcidin, oncorhynchus mykiss hepcidin-containing expression carrier, oncorhynchus mykiss hepcidin-containing strain and applications
03/26/2014CN103667295A siRNA for FOXC1 gene expression inhibition, and application thereof
03/26/2014CN103667292A MicroRNA molecule related to breast cancer docetaxel drug resistance and application thereof
03/26/2014CN103667287A Free triphosphate group-containing GLS (Glutaminase) specific siRNA (Small interfering RNA) and preparation method and applications thereof
03/26/2014CN103667286A Small interfering ribonucleic acid (siRNA) of schistosoma japonicum katsurada membrane-associated progesterone receptor component (PGMRC2) gene and application thereof
03/26/2014CN103667285A SiRNA (small interfering Ribose Nucleic Acid) capable of preventing and controlling influenza, and pharmaceutical composition and medical application thereof
03/26/2014CN103667284A SiRNA for specific inhibition of COTL1 gene expression and application thereof
03/26/2014CN103667198A Construction and application of recombinant duck viral enteritis virus vaccine for expressing secretory duck Tembusu virus E protein
03/26/2014CN103667197A Construction and application of recombinant duck viral enteritis virus vaccine for expressing secretory duck Tembusu virus M/E protein
03/26/2014CN103667190A Method for forming nerve cells by induction and composition
03/26/2014CN103667145A Genetically engineered attenuated strains of edwardsiella tarda (E.tarda) and application thereof
03/26/2014CN103665384A Novel cationic graft copolymer, and preparation method and application of multiple composite non-viral gene vector
03/26/2014CN103665222A Cation functional polymers with natural amino acid as side group, preparation method and application of polymer
03/26/2014CN103665169A Three-function peptide-modified gene carrier as well as preparation method and application thereof
03/26/2014CN103665168A Anti-cd14 antibody-fused protein
03/26/2014CN103656685A Application of micro RNA-219 in preparing antiepileptic drug
03/26/2014CN103656684A Attenuated salmonella typhimurium and application of genetically engineered bacterium of attenuated salmonella typhimurium to preparation of medicines for treating pancreatic cancer
1 ... 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 ... 870